<DOC>
	<DOCNO>NCT01434329</DOCNO>
	<brief_summary>RATIONALE : Studying sample blood bone marrow patient cancer laboratory may help doctor learn change occur DNA identify biomarkers related cancer . It may also help doctor predict patient respond treatment . PURPOSE : This research trial study DNA sample patient acute myeloid leukemia .</brief_summary>
	<brief_title>S8600-S9031-S9333-A , Study DNA Samples From Patients With Acute Myeloid Leukemia</brief_title>
	<detailed_description>OBJECTIVES : - To identify differentially methylated region ( DMRs ) associate overall survival ( OS ) acute myeloid leukemia ( AML ) patient normal cytogenetics . - To develop evaluate independent validation set prognostic score OS base identify DMR . - To determine whether prognostic score group patient risk group base OS . OUTLINE : Archived blood bone marrow sample analyze DNA methylation alteration CHARM array-based genome assay . Each patient 's clinical data also collect .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : De novo acute myeloid leukemia ( AML ) patient normal cytogenetics treat curative therapy survive least 28 day therapy start Samples take follow study : SWOG8600 , SWOG9031 , SWOG9333 , SWOG9500 , SWOGS9918 , SWOGS0106 , SWOGS0112 Blood marrow specimen use PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>untreated adult acute myeloid leukemia</keyword>
</DOC>